May 7, 2026 04:01PM
Mar 25, 2026 04:02PM
Jan 15, 2026 04:22AM
Dec 10, 2025 12:15AM
Dec 10, 2025 12:14AM
Dec 9, 2025 04:01PM
Dec 9, 2025 04:01PM Denali Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants
May 6, 2025 04:01PM
Sep 3, 2024 11:46AM
May 7, 2024 04:01PM
May 8, 2023 04:01PM
Oct 24, 2022 04:30PM
Oct 24, 2022 04:30PM
Oct 20, 2022 03:39AM Denali Therapeutics (DNLI) Prices 10.38M Share Offering at $26.50/sh
Oct 19, 2022 09:19PM
Oct 19, 2022 09:19PM
Oct 18, 2022 04:41PM
Oct 18, 2022 04:40PM
Oct 18, 2022 04:40PM
May 5, 2022 04:01PM
May 5, 2022 04:01PM Denali Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights
Jan 13, 2022 09:27AM
May 3, 2021 08:30AM
May 3, 2021 08:30AM
Feb 25, 2021 04:01PM
Feb 25, 2021 04:01PM
Nov 10, 2020 12:14PM
Nov 6, 2020 01:32PM Denali Therapeutics Inc. (DNLI) PT Raised to $61 at Goldman Sachs, Following Earnings
Feb 28, 2020 01:40PM
Jan 31, 2020 08:42PM
Jan 31, 2020 08:41PM
Jan 31, 2020 08:41PM
Jan 29, 2020 05:51AM
Jan 28, 2020 08:58PM
Jan 28, 2020 08:58PM Denali Therapeutics Announces Pricing of Public Offering of Common Stock
Jan 27, 2020 04:11PM
Jan 27, 2020 04:10PM
Jan 27, 2020 04:10PM
Jan 27, 2020 04:46AM
Jan 2, 2018 02:01AM
Dec 12, 2017 04:10PM
Dec 12, 2017 04:10PM Denali Therapeutics Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Dec 8, 2017 10:57AM
Dec 8, 2017 05:47AM
Dec 7, 2017 07:08PM
Dec 7, 2017 07:08PM

185,288 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All